AMN
AMN
AMN Healthcare Services, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $748.23M ▲ | $152.11M ▲ | $-7.7M ▼ | -1.03% ▼ | $-0.2 ▼ | $45.35M ▼ |
| Q3-2025 | $634.5M ▼ | $138.59M ▼ | $29.29M ▲ | 4.62% ▲ | $0.76 ▲ | $87.25M ▲ |
| Q2-2025 | $658.17M ▼ | $320.11M ▲ | $-116.2M ▼ | -17.66% ▼ | $-3.02 ▼ | $-83.83M ▼ |
| Q1-2025 | $689.53M ▼ | $185.61M ▼ | $-1.09M ▲ | -0.16% ▲ | $-0.03 ▲ | $52.36M ▲ |
| Q4-2024 | $734.71M | $421.54M | $-187.53M | -25.52% | $-4.9 | $-161.08M |
What's going well?
Sales are growing fast, up 18% in just one quarter. Gross profit also increased, and operating expenses grew slower than revenue, showing some cost control.
What's concerning?
Despite higher sales, profits turned negative. Margins are shrinking, and a big negative swing in other income/expense wiped out earnings. The company is now losing money.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $33.97M ▼ | $2.09B ▼ | $1.45B ▼ | $642.11M ▼ |
| Q3-2025 | $52.64M ▲ | $2.14B ▼ | $1.49B ▼ | $644.41M ▲ |
| Q2-2025 | $41.5M ▼ | $2.21B ▼ | $1.6B ▼ | $607.6M ▼ |
| Q1-2025 | $55.78M ▲ | $2.4B ▼ | $1.68B ▼ | $715.05M ▲ |
| Q4-2024 | $10.65M | $2.42B | $1.71B | $706.62M |
What's financially strong about this company?
The company has a long track record of profits and is actively paying down debt. Shareholder equity remains positive, and there are no large hidden liabilities.
What are the financial risks or weaknesses?
Cash is low and liquidity is tight, with current assets not enough to cover short-term bills. The company relies heavily on debt and has a lot of goodwill from past acquisitions, which could be risky if business slows.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-7.7M ▼ | $75.57M ▲ | $-8.05M ▼ | $-83.24M ▼ | $-15.72M ▼ | $75.57M ▲ |
| Q3-2025 | $29.29M ▲ | $22.67M ▼ | $58.99M ▲ | $-71.21M ▲ | $10.44M ▲ | $14.76M ▼ |
| Q2-2025 | $-116.2M ▼ | $78.55M ▼ | $-20.59M ▲ | $-80.23M ▼ | $-8.73M ▼ | $68.75M ▼ |
| Q1-2025 | $-1.09M ▲ | $92.67M ▲ | $-26.05M ▼ | $-61.21M ▲ | $5.41M ▲ | $82.7M ▲ |
| Q4-2024 | $-187.53M | $72.81M | $-14.2M | $-79.9M | $-21.29M | $56.59M |
What's strong about this company's cash flow?
The company turned a net loss into strong cash flow, producing $75.6 million from operations. No debt or equity funding was needed, and free cash flow improved sharply from last quarter.
What are the cash flow concerns?
Cash balance shrank by $15.7 million, and the net loss raises questions about future profitability. No cash was returned to shareholders, and the improvement in cash flow may not be consistent.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Other Solutions | $0 ▲ | $0 ▲ | $10.00M ▲ | $0 ▼ |
Permanent Placement | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Technology Enabled Services | $100.00M ▲ | $100.00M ▲ | $90.00M ▼ | $0 ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at AMN Healthcare Services, Inc.'s financial evolution and strategic trajectory over the past five years.
AMN’s strengths include its leading market position in healthcare staffing, broad service offering across clinical and non‑clinical roles, and deep relationships with large health systems. Its technology platforms and data assets create meaningful differentiation versus smaller or less sophisticated rivals. Historically strong cash generation and a substantial intangible asset base show that the business model can be very profitable when demand and pricing are favorable.
Key risks center on the pronounced deterioration in revenue and profitability since the peak years, with margins now negative and cash generation in decline. Higher leverage and weaker liquidity reduce financial flexibility just as the company faces cyclical and competitive pressures. Additional concerns include potential underinvestment in future growth, ongoing dependence on hospital budgets and reimbursement trends, and the risk that technology‑driven competitors or internal hospital staffing solutions capture more of the value chain.
The outlook is mixed: structurally, healthcare labor shortages and the need for flexible staffing should support long‑term demand, but cyclically the business is in a down phase as the post‑pandemic surge unwinds and clients work to lower labor costs. AMN’s scale and technology give it tools to navigate this period, yet restoring revenue growth and margin health will likely require both a more favorable demand environment and continued execution on its digital workforce strategy. Overall, the company appears to be in a transition from a boom‑time peak toward a more normalized, and currently more challenging, operating reality.
About AMN Healthcare Services, Inc.
https://www.amnhealthcare.comAMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $748.23M ▲ | $152.11M ▲ | $-7.7M ▼ | -1.03% ▼ | $-0.2 ▼ | $45.35M ▼ |
| Q3-2025 | $634.5M ▼ | $138.59M ▼ | $29.29M ▲ | 4.62% ▲ | $0.76 ▲ | $87.25M ▲ |
| Q2-2025 | $658.17M ▼ | $320.11M ▲ | $-116.2M ▼ | -17.66% ▼ | $-3.02 ▼ | $-83.83M ▼ |
| Q1-2025 | $689.53M ▼ | $185.61M ▼ | $-1.09M ▲ | -0.16% ▲ | $-0.03 ▲ | $52.36M ▲ |
| Q4-2024 | $734.71M | $421.54M | $-187.53M | -25.52% | $-4.9 | $-161.08M |
What's going well?
Sales are growing fast, up 18% in just one quarter. Gross profit also increased, and operating expenses grew slower than revenue, showing some cost control.
What's concerning?
Despite higher sales, profits turned negative. Margins are shrinking, and a big negative swing in other income/expense wiped out earnings. The company is now losing money.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $33.97M ▼ | $2.09B ▼ | $1.45B ▼ | $642.11M ▼ |
| Q3-2025 | $52.64M ▲ | $2.14B ▼ | $1.49B ▼ | $644.41M ▲ |
| Q2-2025 | $41.5M ▼ | $2.21B ▼ | $1.6B ▼ | $607.6M ▼ |
| Q1-2025 | $55.78M ▲ | $2.4B ▼ | $1.68B ▼ | $715.05M ▲ |
| Q4-2024 | $10.65M | $2.42B | $1.71B | $706.62M |
What's financially strong about this company?
The company has a long track record of profits and is actively paying down debt. Shareholder equity remains positive, and there are no large hidden liabilities.
What are the financial risks or weaknesses?
Cash is low and liquidity is tight, with current assets not enough to cover short-term bills. The company relies heavily on debt and has a lot of goodwill from past acquisitions, which could be risky if business slows.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-7.7M ▼ | $75.57M ▲ | $-8.05M ▼ | $-83.24M ▼ | $-15.72M ▼ | $75.57M ▲ |
| Q3-2025 | $29.29M ▲ | $22.67M ▼ | $58.99M ▲ | $-71.21M ▲ | $10.44M ▲ | $14.76M ▼ |
| Q2-2025 | $-116.2M ▼ | $78.55M ▼ | $-20.59M ▲ | $-80.23M ▼ | $-8.73M ▼ | $68.75M ▼ |
| Q1-2025 | $-1.09M ▲ | $92.67M ▲ | $-26.05M ▼ | $-61.21M ▲ | $5.41M ▲ | $82.7M ▲ |
| Q4-2024 | $-187.53M | $72.81M | $-14.2M | $-79.9M | $-21.29M | $56.59M |
What's strong about this company's cash flow?
The company turned a net loss into strong cash flow, producing $75.6 million from operations. No debt or equity funding was needed, and free cash flow improved sharply from last quarter.
What are the cash flow concerns?
Cash balance shrank by $15.7 million, and the net loss raises questions about future profitability. No cash was returned to shareholders, and the improvement in cash flow may not be consistent.
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Other Solutions | $0 ▲ | $0 ▲ | $10.00M ▲ | $0 ▼ |
Permanent Placement | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Technology Enabled Services | $100.00M ▲ | $100.00M ▲ | $90.00M ▼ | $0 ▼ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at AMN Healthcare Services, Inc.'s financial evolution and strategic trajectory over the past five years.
AMN’s strengths include its leading market position in healthcare staffing, broad service offering across clinical and non‑clinical roles, and deep relationships with large health systems. Its technology platforms and data assets create meaningful differentiation versus smaller or less sophisticated rivals. Historically strong cash generation and a substantial intangible asset base show that the business model can be very profitable when demand and pricing are favorable.
Key risks center on the pronounced deterioration in revenue and profitability since the peak years, with margins now negative and cash generation in decline. Higher leverage and weaker liquidity reduce financial flexibility just as the company faces cyclical and competitive pressures. Additional concerns include potential underinvestment in future growth, ongoing dependence on hospital budgets and reimbursement trends, and the risk that technology‑driven competitors or internal hospital staffing solutions capture more of the value chain.
The outlook is mixed: structurally, healthcare labor shortages and the need for flexible staffing should support long‑term demand, but cyclically the business is in a down phase as the post‑pandemic surge unwinds and clients work to lower labor costs. AMN’s scale and technology give it tools to navigate this period, yet restoring revenue growth and margin health will likely require both a more favorable demand environment and continued execution on its digital workforce strategy. Overall, the company appears to be in a transition from a boom‑time peak toward a more normalized, and currently more challenging, operating reality.

CEO
Caroline Sullivan Grace
Compensation Summary
(Year 2008)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 185
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Citizens
Market Outperform
Baird
Neutral
UBS
Neutral
BMO Capital
Outperform
Truist Securities
Buy
B of A Securities
Underperform
Grade Summary
Showing Top 6 of 7
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:6.21M
Value:$121.06M
BLACKROCK, INC.
Shares:5.92M
Value:$115.34M
VANGUARD GROUP INC
Shares:4.39M
Value:$85.49M
Summary
Showing Top 3 of 407

